These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 8647231
1. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA. Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [Abstract] [Full Text] [Related]
7. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma. Iyer VK, Raina V, Dawar R. Indian J Cancer; 2000 Dec 01; 37(4):140-7. PubMed ID: 12018565 [Abstract] [Full Text] [Related]
11. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K. Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690 [Abstract] [Full Text] [Related]
12. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Federico M, Clò V, Brugiatelli M, Carotenuto M, Gobbi PG, Vallisa D, Lombardo M, Avanzini P, Di Renzo N, Dini D, Baldini L, Silingardi V. Haematologica; 1998 Sep 15; 83(9):800-11. PubMed ID: 9825577 [Abstract] [Full Text] [Related]
15. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, Kanno S, Saito K. Cancer; 1998 Jan 01; 82(1):86-95. PubMed ID: 9428483 [Abstract] [Full Text] [Related]
16. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas. Mikou P, Kanavaros P, Aninos D, Tzardi M, Karameris A, Gorgoulis B, Papadopoulos N, Lavergne A, Galian A. Pathol Res Pract; 1993 Nov 01; 189(9):1004-9. PubMed ID: 7905623 [Abstract] [Full Text] [Related]
18. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma]. Kamieńska E. Ann Acad Med Stetin; 1996 Nov 01; 42():105-22. PubMed ID: 9199116 [Abstract] [Full Text] [Related]
20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]